Zacks Investment Research downgraded shares of VWR Corporation (NASDAQ:VWR) from a buy rating to a hold rating in a report released on Monday.

According to Zacks, “VWR’s second-quarter earnings report was quite impressive, with both the top and the bottom line beating the Zacks Consensus Estimate. Geographically, the company recorded growth in Americas during the reported quarter driven by strong sales of equipment and instrumentation. Management is also looking forward to the long-term synergy benefits from the proposed merger with Avantor. The merger is expected to strengthen VWR’s business across the Americas and Europe. While we await the merger to close in the fourth quarter of 2017 we note that the stock price has already reached close to Avantor’s offer price and hence the short-term upside potential of VWR is limited now. On the flip side, a drop in EMEA-APAC sales was disappointing. Moreover, foreign currency was a major dampener. VWR’s poor margin scenario also raises concern.”

A number of other research analysts have also recently weighed in on the stock. William Blair cut shares of VWR Corporation from an outperform rating to a market perform rating in a research report on Monday, May 15th. BidaskClub cut shares of VWR Corporation from a sell rating to a strong sell rating in a research report on Thursday, July 27th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. The company has an average rating of Hold and an average price target of $30.50.

Shares of VWR Corporation (NASDAQ:VWR) opened at 33.02 on Monday. The stock has a market capitalization of $4.35 billion, a price-to-earnings ratio of 30.57 and a beta of 1.19. The stock has a 50 day moving average price of $33.00 and a 200 day moving average price of $30.92. VWR Corporation has a 1-year low of $24.42 and a 1-year high of $37.25.

VWR Corporation (NASDAQ:VWR) last announced its quarterly earnings results on Monday, July 31st. The medical research company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.45 by $0.04. The firm had revenue of $1.18 billion for the quarter, compared to analysts’ expectations of $1.16 billion. VWR Corporation had a net margin of 3.12% and a return on equity of 15.54%. VWR Corporation’s revenue was up 2.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.42 earnings per share. Equities research analysts anticipate that VWR Corporation will post $1.87 EPS for the current year.

WARNING: “VWR Corporation (VWR) Downgraded to “Hold” at Zacks Investment Research” was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this piece on another publication, it was stolen and republished in violation of United States & international trademark and copyright laws. The correct version of this piece can be read at https://www.watchlistnews.com/vwr-corporation-vwr-downgraded-to-hold-at-zacks-investment-research/1535549.html.

Several hedge funds and other institutional investors have recently bought and sold shares of VWR. FNY Managed Accounts LLC purchased a new position in VWR Corporation during the first quarter worth approximately $100,000. First Mercantile Trust Co. boosted its position in VWR Corporation by 195.2% in the first quarter. First Mercantile Trust Co. now owns 6,200 shares of the medical research company’s stock worth $175,000 after buying an additional 4,100 shares during the last quarter. Teacher Retirement System of Texas purchased a new position in VWR Corporation during the first quarter worth approximately $205,000. Neuberger Berman Group LLC purchased a new position in VWR Corporation during the first quarter worth approximately $219,000. Finally, PNC Financial Services Group Inc. boosted its position in VWR Corporation by 954.2% in the first quarter. PNC Financial Services Group Inc. now owns 8,455 shares of the medical research company’s stock worth $238,000 after buying an additional 7,653 shares during the last quarter.

VWR Corporation Company Profile

VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC.

Get a free copy of the Zacks research report on VWR Corporation (VWR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for VWR Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VWR Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.